Kindly take note of the same on your records.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Symbiox Investment & Trading Company Ltd filed its Annual Secretarial Compliance Report for FY 2024-25, certified by Practicing Company Secretary Akhil Agarwal. The report confirms the company is broadly compliant with SEBI regulations covering secretarial standards, insider trading rules, related party transactions, timely disclosures, and director eligibility. No actions were taken by SEBI or stock exchanges against the company or its directors during the review period. Two minor non-compliances were noted: a BSE query about non-submission of the Statement on Impact of Audit Qualifications in XBRL format for FY24 (now resolved), and an older Reg 23(9) related-party disclosure lapse from March 2023 that attracted fines of Rs 17,700 each from BSE and MSE, which the company states is still being resolved.
This is a routine annual regulatory compliance submission with no material red flags. The flagged issues are minor and largely historical, with limited expected impact on the stock price or shareholder value.